Stay updated with breaking news from Reverse Transcriptase Inhibitor. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
--Poster highlights potential of oral small molecule IFNAR agonist program to engage the IFNα pathway through a liver-focused approach to improve tolerability-- SOUTH SAN FRANCISCO, Calif., Nov. ...
Antiviral drugs can suppress tumor adaptation to treatment and dramatically extend progression-free survival.
A drug widely used in HIV therapy has shown to stop disease progression in 25 percent of patients with fourth-line metastatic colorectal cancer.
Lexaria Bioscience Corp.: Lexaria Expands COVID-19 Drug Research Program Utilizing Proprietary DehydraTECH Remdesivir is one of several drugs to be evaluated KELOWNA, BC / ACCESSWIRE / December 22, 2020 / Lexaria Bioscience Corp. (OTCQX:LXRP)(CSE:LXX) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms, today announced that it has initiated the next phase of its antiviral drug research program following successful results from a recent animal study announced on December 1, 2020. The recent animal study demonstrated that DehydraTECH TM technology significantly improved ...